Skip to main content
SpringerLink
Log in

IMMUNATE S/D — A new Factor VIII — von-Willebrand Factor Complex Concentrate

  • Conference paper
33rd Hemophilia Symposium

Abstract

IMMUNATE is a human plasma-derived coagulation factor VIII concentrate containing both factor VIII (FVIII) and von-Willebrand Factor (vWF) produced by Baxter AG and currently approved in a large number of countries in Europe and overseas. The complex is purified by anion-exchange chromatography. IMMUNATE’s manufacturing process also includes two virus inactivation steps:

  1. 1.

    treatment with polysorbate 80, and

  2. 2.

    vapor heat treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brettler DB, Levine PH. Factor concentrates for treatment of hemophilia: which one to choose? Blood 1989; 73: 2067–2073

    PubMed  CAS  Google Scholar 

  2. Mannucci PM. The choice of plasma-derived clotting factor concentrates. Baillieres Clin Haematol 1996; 9: 273–290

    Article  PubMed  CAS  Google Scholar 

  3. Rodgers GM, Greenberg CS. Inherited coagulation disorders. In: Lee GR, Foerster J, Lukens J, Paraskevas F, Greer JP, Rodgers GM, eds. Vol. 2: Wintrobe’s Clinical Hematology. Baltimore, MD: Lippincott Williams & Wilkins; 1999: 1682–1732

    Google Scholar 

  4. Eriksson B, Westman L, Jernberg M. Virus validation of plasma-derived products produced by Pharmacia, with particular reference to immunoglobulins. Blood Coagul Fibrinolysis 1994; 5(Suppl 3): S37–S44

    Article  PubMed  CAS  Google Scholar 

  5. Barrett PN, Meyer H, Wachtel I, Eibl J, Dorner F. Determination of the inactivation kinetics of hepatitis A virus in human plasma products using a simple TCID50 assay. J Med Virol 1996; 49: 1–6

    Article  PubMed  CAS  Google Scholar 

  6. Mannucci PM, Schimpf K, Abe T, Aledort LM, Anderle K, Brettler DB, Hilgartner MW, Kernoff PBA, Kunschak M, McMillan CW, Preston FE, Rivard GE. Low risk of viral infection after administration of vapor-heated factor VIII concentrate. Transfusion 1992; 32: 134–138

    Article  PubMed  CAS  Google Scholar 

  7. Mannucci PM. Clinical evaluation of viral safety of coagulation factor VIII and IX concen-trates. Vox Sang 1993; 64: 197–203

    Article  PubMed  CAS  Google Scholar 

  8. Shapiro A, Abe T, Aledort LM, Anderle K, Hilgartner MW, Kunschak M, Preston FE, Rivard GE, Schimpf K and The International Factor Safety Study Group. Low risk of viral infection after administration of vapor-heated factor VII concentrate or factor IX complex in firsttime recipients of blood components. Transfusion 1995; 35: 204–208

    Article  PubMed  CAS  Google Scholar 

  9. Horowitz B, Bonomo R, Prince AM, Chin SN, Brotman B, Shulman RW. Solvent/detergent-treated plasma: a virus-inactivated substitute for fresh frozen plasma. Blood 1992; 79: 826–831

    PubMed  CAS  Google Scholar 

  10. Committee for Proprietary Medicinal Products (CPMP) Note for Guidance on Virus Validation Studies: The Design, Contribution and Interpretation of Studies Validating the Inactivation and Removal of Viruses.CPMP/BWP/268/95. 1996. London, European Agency for the Evaluation of Medicinal Products.

    Google Scholar 

  11. Bi L, Lawler AM, Antonarakis SE, High KA, Gearhart JD, Kazazian HH, Jr. Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nat Genet 1995; 10: 119–121

    Article  PubMed  CAS  Google Scholar 

  12. Reipert BM, Ahmad RU, Turecek PL, Schwarz HP. Characterization of antibodies induced by human factor VIII in a murine knockout model of hemophilia A. Thromb Haemost 2000; 84(5): 826–832

    PubMed  CAS  Google Scholar 

  13. Muchitsch EM, Pichler L, Turecek PL, Gritsch H, Richter G, Auer W, Schwarz HP. Charakterisierung der Faktor VIII-knockout-Maus für den Einsatz in der biomedizinischen Forschung (Characterization of FVIII knockout mice: A new tool in biomedical research). Wien Tierärztl Mschr 1999; 86: 339–346

    CAS  Google Scholar 

  14. Muchitsch EM, Auer W, Pichler L, Turecek PL, Zimmermann K, Richter G, Gritsch H, Schwarz HP. Phenotypic expression of murine haemophilia — Letter to the Editor. Thromb Haemost 1999; 82(4): 1371–1373

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. P. L. Turecek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Schönhofer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. R. Kreil
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Weber
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K. Váradi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. Gritsch
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J. Siekmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. L. Pichler
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. B. M. Reipert
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. B. Abbühl
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. H. P. Schwarz
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hemophilia Center, Dept. of Internal Medicine, University Hospital, Theodor-Stern-Kai 7, D-60590, Frankfurt am Main, Germany

    Inge Scharrer

  2. Dept. of Hemostaseology, University Hospital, Ziemssenstr. 1a, D-80336, München, Germany

    Wolfgang Schramm

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Turecek, P.L. et al. (2004). IMMUNATE S/D — A new Factor VIII — von-Willebrand Factor Complex Concentrate. In: Scharrer, I., Schramm, W. (eds) 33rd Hemophilia Symposium. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18260-0_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-18260-0_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-00902-3

  • Online ISBN: 978-3-642-18260-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation